SARS vaccine tests well in mouse model

A vaccine that targets the virus responsible for severe acute respiratory syndrome (SARS) stops the infection in mice, scientists report.

Researchers fashioned the vaccine from a piece of viral DNA that includes the gene for a surface protein on the SARS virus. When injected into mice, the DNA becomes housed in mouse cells, which then use the genetic instructions to produce the viral protein.